Respiratory Syncytial Virus (RSV): Advisory Committee on Immunization Practices (ACIP) Recommendations
Access Resources
About
The Advisory Committee on Immunization Practices (ACIP) provides guidelines for preventing Respiratory Syncytial Virus (RSV). Infants up to 8 months should get a dose of nirsevimab unless their mother was vaccinated during pregnancy. Children at risk aged 8-19 months should also receive it. Adults over 75 and those aged 60-74 at high risk need an RSV vaccine. Nirsevimab helps prevent severe RSV in infants, while vaccines like Arexvy and Abrysvo are used for older adults. The text highlights the importance of vaccination to reduce hospitalizations and deaths caused by RSV-related illnesses across different age groups.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.